Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration

BACKGROUND: JAK-inhibitors (JAKi), recently approved in rheumatoid arthritis (RA), have changed the landscape of treatment choices. We aimed to compare the effectiveness of four current second-line therapies of RA with different modes of action, since JAKi approval, in an international collaboration...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ANNALS OF THE RHEUMATIC DISEASES 2022-10, Vol.81 (10), p.1358-1366
Hauptverfasser:	Lauper, Kim, Ludici, Michele, Mongin, Denis, Bergstra, Sytske Anne, Choquette, Denis, Codreanu, Catalin, Cordtz, Rene, De Cock, Diederik, Dreyer, Lene, Elkayam, Ori, Hauge, Ellen-Margrethe, Huschek, Doreen, Hyrich, Kimme L, Iannone, Florenzo, Inanc, Nevsun, Kearsley-Fleet, Lianne, Kristianslund, Eirik Klami, Kvien, Tore K, Leeb, Burkhard F, Lukina, Galina, Nordstrom, Dan C, Pavelka, Karel, Pombo-Suarez, Manuel, Rotar, Ziga, Santos, Maria Jose, Strangfeld, Anja, Verschueren, Patrick, Courvoisier, Delphine Sophie, Finckh, Axel
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!